IBAT inhibitors, elastography and more
Cleveland Clinic specialists discuss challenges and opportunities for managing the disease
More accurate than existing noninvasive tests
Method can eliminate need for liver biopsies in significant number of patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study finds a 43% lower risk of HCC in statin users
A quick review of several advances in risk assessment and treatment
Treating OSA could improve quality of life for liver disease patients
Biomarkers urgently needed
Advertisement
Advertisement